Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Johannes B. Goll

Phase II Randomized, Double-Blinded Comparison of a Single High Dose (5×108 TCID50) of Modified Vaccinia Ankara Compared to a Standard Dose (1×108 TCID50) in Healthy Vaccinia-Naïve Individuals

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2014English

RSEQREP: RNA-Seq Reports, an Open-Source Cloud-Enabled Framework for Reproducible RNA-Seq Data Processing, Analysis, and Result Reporting

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Related publications

Immunogenicity of Recombinant Modified Vaccinia Ankara Following a Single or Multi-Dose Vaccine Regimen in Rhesus Monkeys

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2009English

A Double-Blinded Randomised Placebo-Controlled Phase II Trial to Evaluate High Dose Rifampicin for Tuberculous Meningitis: A Dose Finding Study

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

834 Rational Design of Recombinant Modified Vaccinia Virus Ankara for Cancer Immunotherapy

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Attenuation and Immunogenicity of Host-Range Extended Modified Vaccinia Virus Ankara Recombinants

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2013English

The Standard Dose Versus Double Dose of N-Acetylcysteine to Prevent Contrast-Induced Nephropathy; A Randomized Controlled Clinical Trial

Journal of Nephropathology
Nephrology
2018English

Expanding the Repertoire of Modified Vaccinia Ankara-Based Vaccine Vectors via Genetic Complementation Strategies

PLoS ONE
Multidisciplinary
2009English

Highly Attenuated Modified Vaccinia Virus Ankara (MVA) as an Effective Recombinant Vector: A Murine Tumor Model

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
1997English

Single Dose Gadobenate Dimeglumine for Imaging Chronic of Myocardial Infarction in Comparison to Double Dose Gadopentetate Dimeglumine

Journal of Cardiovascular Magnetic Resonance
Nuclear MedicineRadiologyUltrasound TechnologyCardiologyFamily PracticeRadiologicalCardiovascular MedicineImaging
2009English

088 Skin Delivery of Modified Vaccinia Ankara (MVA) Virus Generates Superior Protective Pulmonary Immunity

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy